Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2014-11-16 | Reverse | 1:10 |
Penumbra, Inc. develops and markets innovative medical devices—including thrombectomy, neurovascular, and neurosurgical tools—for vascular and neurovascular treatments worldwide.

Lightning Flash 3.0 is Penumbra's advanced CAVT system for rapid, efficient blood clot removal in veins and pulmonary arteries, featuring enhanced detection and automated backflush for faster, safer procedures.
| Icon | PRODUCT | Q4-2022 | Q1-2023 | Q2-2023 | Q3-2023 |
|---|---|---|---|---|---|
![]() | Neuro | $91.54M | $98.55M ▲ | $108.81M ▲ | $171.41M ▲ |
![]() | Peripheral Vascular | $129.68M | $142.85M ▲ | $152.68M ▲ | $99.54M ▼ |
| Map | REGION | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | UNITED STATES | $275.03M | $299.05M ▲ | $296.39M ▼ | $305.44M ▲ |
![]() | NonUS | — | — | $78.37M | $84.6M ▲ |
![]() | Other NonUS | $79.66M | — | — | — |
Overall rating: B
| PEER | PRICE | |
|---|---|---|
CRL | $291.50 | COMPARE |
BAX | $26.13 | COMPARE |
DVA | $180.68 | COMPARE |
ALGN | $157.58 | COMPARE |
GMED | $82.97 | COMPARE |
BIO | $387.70 | COMPARE |
HSIC | $89.52 | COMPARE |
HQY | $96.37 | COMPARE |